BMC Neurol

1. SSEMMANDA S, Musubire AK
   Different clinical phenotypes of AQP4-IgG positive NMOSD in two first degree relatives.
   BMC Neurol. 2023;23:315.
   

   >> Share

   
   
2. SHAHRAKI Z, Rastkar M, Rastkar E, Mohammadifar M, et al
   Impact of menopause on relapse rate and disability level in patients with multiple sclerosis (MS): a systematic review and meta-analysis.
   BMC Neurol. 2023;23:316.
   

   >> Share

   
   

   
   Brain

3. MATSUMOTO Y, Kaneko K, Takahashi T, Takai Y, et al
   Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids.
   Brain. 2023;146:3938-3948.
   

   >> Share

   
   

   
   Intern Med

4. AKITA S, Fujibayashi K, Ueno EI, Wakasa M, et al
   Thrombotic Microangiopathy after a 15-year Treatment with Interferon Beta-1b in a Patient with Multiple Sclerosis: A Case Report and Review of Literature.
   Intern Med. 2023 Sep 1. doi: 10.2169/internalmedicine.1846.
   

   >> Share

   
   
5. KATSUO C, Kubota K, Tanaka K, Kurita Y, et al
   Erratum for Combined REGN-COV2 Antibody Therapy Immediately Prevented a Patient with Refractory Type 1 Autoimmune Pancreatitis from Contracting SARS-CoV-2 during the Sixth Wave in Japan.
   Intern Med. 2023;62:2595.
   

   >> Share

   
   

   
   J Nephrol

6. BAIER E, Kluge IA, Hakroush S, Tampe B, et al
   Low hemoglobin levels are associated with Bowman's capsule rupture and peritubular capillaritis in ANCA-associated renal vasculitis: a link of vascular injury to anemia?
   J Nephrol. 2023 Sep 7. doi: 10.1007/s40620-023-01748.
   

   >> Share

   
   
7. DIRIM AB, Agargun BF, Hurdogan O, Ozluk Y, et al
   Two cases of IgA nephropathy after splenectomy: spleen as a silent culprit in the pathogenesis of IgA nephropathy.
   J Nephrol. 2023 Sep 4. doi: 10.1007/s40620-023-01764.
   

   >> Share

   
   

   
   J Neuroimmunol

8. KHAN E, Kagzi Y, Elkhooly M, Surpur S, et al
   Disease modifying therapy and pregnancy outcomes in multiple sclerosis: A systematic review and meta-analysis.
   J Neuroimmunol. 2023;383:578178.
   

   >> Share

   
   

   
   J Neurol

9. JACOBS BM, Tank P, Bestwick JP, Noyce AJ, et al
   Modifiable risk factors for multiple sclerosis have consistent directions of effect across diverse ethnic backgrounds: a nested case-control study in an English population-based cohort.
   J Neurol. 2023 Sep 7. doi: 10.1007/s00415-023-11971.
   

   >> Share

   
   

   
   J Rheumatol

10. FERUCCI ED
    Improving Outcomes in Systemic Lupus Erythematosus: The Importance of Access to Medications.
    J Rheumatol. 2023 Sep 1:jrheum.2023-0772. doi: 10.3899/jrheum.2023-0772.
    

    >> Share

    
    
11. MOISEEV S, Bulanov N, Crnogorac M, Direskeneli H, et al
    Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multinational Retrospective Study.
    J Rheumatol. 2023;50:1145-1151.
    

    >> Share

    
    
12. WEISS PF, Brandon TG, Lambert RG, Biko DM, et al
    Consensus-Driven Definition for Unequivocal Sacroiliitis on Radiographs in Juvenile Spondyloarthritis.
    J Rheumatol. 2023;50:1173-1177.
    

    >> Share

    
    
13. YOSHIDA Y, Nakamoto N, Oka N, Kidoguchi G, et al
    Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS).
    J Rheumatol. 2023;50:1152-1158.
    

    >> Share

    
    

    
    Mult Scler

14. GABRIELLI M, Verderio C
    Exosomal profiling should be used to monitor disease activity in MS patients: Commentary.
    Mult Scler. 2023 Sep 7:13524585231195858. doi: 10.1177/13524585231195858.
    

    >> Share

    
    
15. DELTOMBE M, van Pesch V
    Exosomal profiling should be used to monitor disease activity in MS patients: No.
    Mult Scler. 2023 Sep 7:13524585231195859. doi: 10.1177/13524585231195859.
    

    >> Share

    
    
16. MYCKO MP
    Exosomal profiling should be used to monitor disease activity in MS patients: Yes.
    Mult Scler. 2023 Sep 7:13524585231195860. doi: 10.1177/13524585231195860.
    

    >> Share

    
    

    
    N Engl J Med

17. DANDONA P, Chaudhuri A, Ghanim H
    Semaglutide in Early Type 1 Diabetes.
    N Engl J Med. 2023;389:958-959.
    

    >> Share

    
    

    
    Neurol Clin Pract

18. KISTER I, Oh C, Douglas EA, Bacon TE, et al
    No Increase in Symptoms Toward the End of the Ocrelizumab Infusion Cycle in Patients With Multiple Sclerosis: Symptom Burden on Ocrelizumab: A Longitudinal Study (SymBOLS).
    Neurol Clin Pract. 2023;13:e200185.
    

    >> Share

    
    

    
    Neurologia (Engl Ed)

19. ALBA SUAREZ EM, Tallon Barranco A, Puertas Munoz I, Chamorro Hernandez B, et al
    Non-late-onset neutropaenia following treatment of multiple sclerosis with ocrelizumab.
    Neurologia (Engl Ed). 2023;38:463-466.
    

    >> Share

    
    

    
    Neurology

20. ALMRAMHI MM, Finan C, Storm CS, Schmidt AF, et al
    Exploring the Role of Plasma Lipids and Statins Interventions on Multiple Sclerosis Risk and Severity: A Mendelian Randomization Study.
    Neurology. 2023 Sep 1:10.1212/WNL.0000000000207777.
    

    >> Share

    
    
21. BUYUKKURT A, Harroud A
    The Potential to Inform Statin Use in Multiple Sclerosis Through Human Genetics [re: WNL-2023-000524].
    Neurology. 2023 Sep 1:10.1212/WNL.0000000000207773.
    

    >> Share

    
    

    
    PLoS One

22. TEKIN H, Frobert O, Graesli AR, Kindberg J, et al
    Hibernation and plasma lipids in free-ranging brown bears-implications for diabetes.
    PLoS One. 2023;18:e0291063.
    

    >> Share

    
    
23. LIN DY, Andreotti AH
    Structure of BTK kinase domain with the second-generation inhibitors acalabrutinib and tirabrutinib.
    PLoS One. 2023;18:e0290872.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

24. GAN T, Wang D
    Picobirnaviruses encode proteins that are functional bacterial lysins.
    Proc Natl Acad Sci U S A. 2023;120:e2309647120.
    

    >> Share

    
    
25. GARCIA CORRALES AV, Verberk SGS, Haidar M, Grajchen E, et al
    Fatty acid elongation by ELOVL6 hampers remyelination by promoting inflammatory foam cell formation during demyelination.
    Proc Natl Acad Sci U S A. 2023;120:e2301030120.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share